A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.
Public ClinicalTrials.gov record NCT02914275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Multicenter, Observer-blinded, Noninferiority Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Inactivated Influenza Virus Vaccine (Seqirus QIV) With a US-licensed Quadrivalent Inactivated Comparator Influenza Virus Vaccine (Comparator QIV) in a Pediatric Population 6 Months Through 59 Months of Age
Study identification
- NCT ID
- NCT02914275
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Seqirus
- Industry
- Enrollment
- 2,250 participants
Conditions and interventions
Conditions
Interventions
- Seqirus Quadrivalent Inactivated Influenza Vaccine Biological
- Comparator Quadrivalent Inactivated Influenza Vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 6 Months to 59 Months
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 26, 2016
- Primary completion
- Mar 8, 2017
- Completion
- Aug 10, 2017
- Last update posted
- Jan 22, 2019
2016 – 2017
United States locations
- U.S. sites
- 39
- U.S. states
- 15
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 434 | Birmingham | Alabama | 35205 | — |
| Site 442 | Mobile | Alabama | 36608 | — |
| Site 430 | Anaheim | California | 92804 | — |
| Site 437 | Anaheim | California | 92804 | — |
| Site 423 | Downey | California | 90241 | — |
| Site 397 | Ontario | California | 91762 | — |
| Site 445 | Paramount | California | 90723 | — |
| Site 402 | Sacramento | California | 95822 | — |
| Site 425 | San Diego | California | 92103 | — |
| Site 418 | Miami | Florida | 33175 | — |
| Site 426 | Miami | Florida | 33176 | — |
| Site 289 | Meridian | Idaho | 83642 | — |
| Site 390 | Augusta | Kansas | 67010 | — |
| Site 421 | Newton | Kansas | 67114 | — |
| Site 422 | Wichita | Kansas | 67205 | — |
| Site 443 | Louisville | Kentucky | 40202 | — |
| Site 420 | Louisville | Kentucky | 40291 | — |
| Site 441 | Louisville | Kentucky | 40291 | — |
| Site 393 | Metairie | Louisiana | 70002 | — |
| Site 436 | Metairie | Louisiana | 70006 | — |
| Site 285 | Binghamton | New York | 13901 | — |
| Site 429 | Asheboro | North Carolina | 27203 | — |
| Site 446 | Cincinnati | Ohio | 45229 | — |
| Site 427 | Dayton | Ohio | 45419 | — |
| Site 419 | Charleston | South Carolina | 29407 | — |
| Site 439 | Spartanburg | South Carolina | 29303 | — |
| Site 308 | Bristol | Tennessee | 37620 | — |
| Site 444 | Kingsport | Tennessee | 37660 | — |
| Site 283 | Austin | Texas | 78705 | — |
| Site 282 | Fort Worth | Texas | 76135 | — |
| Site 288 | San Angelo | Texas | 76904 | — |
| Site 395 | Layton | Utah | 84041 | — |
| Site 431 | Salt Lake City | Utah | 84109 | — |
| Site 424 | Salt Lake City | Utah | 84121 | — |
| Site 428 | Salt Lake City | Utah | 84124 | — |
| Site 440 | West Jordan | Utah | 84084 | — |
| Site 433 | West Jordan | Utah | 84088 | — |
| Site 435 | West Jordan | Utah | 84088 | — |
| Site 438 | Charlottesville | Virginia | 22902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02914275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 22, 2019 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02914275 live on ClinicalTrials.gov.